Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease

Similar documents
Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

Barrett s Esophagus: Old Dog, New Tricks

Barrett s Esophagus. lining of the lower esophagus that bears his name (i.e., Barrett's esophagus). We now

Definition of GERD American College of Gastroenterology

New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus

Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?

AGA SECTION. Gastroenterology 2016;150:

ORIGINAL ARTICLE. Adenocarcinoma of the Esophagus With and Without Barrett Mucosa

Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery

GASTROESOPHAGEAL REFLUX

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

FREQUENCY, TYPES AND COMPLICATIONS OF BARRETT S ESOPHAGUS IN PATIENTS WITH SYMPTOMS OF GASTRO-ESOPHAGEAL REFLUX

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

Putting Chronic Heartburn On Ice

THE CONNECTIVE TISSUE AND EPITHELIUM

Gastroesophageal Reflux Disease in Infants and Children

Is Radiofrequency Ablation Effective In Treating Barrett s Esophagus Patients with High-Grade Dysplasia?

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

HELICOBACTER PYLORI; PATIENTS WITH FUNCTIONAL DYSPEPSIA

Achalasia is a rare disease with an annual incidence estimated REVIEWS. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia

B. Cystic Teratoma: Refer to virtual microscope slide p_223 ovary, teratoma and compare to normal virtual microscope slide 086 ovary.

Adenocarcinoma of the distal esophagus is a recognized

WHAT IS GASTROESOPHAGEAL REFLUX DISEASE (GERD)?

GI update. Common conditions and concerns my patients frequently asked about

Management of Barrett s Esophagus. Case Presentation

David Markowitz, MD. Physicians and Surgeons

Barrett esophagus. Bible class Inselspital

Pathology of the oesophagus and the stomach. Neil A Shepherd Gloucester, UK. Bristol Pathology 1 st Year Training School, The layers of the GI tract

Histopathology: gastritis and peptic ulceration

In 1998, the American College of Gastroenterology issued ALIMENTARY TRACT

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Chapter 14: Training in Radiology. DDSEP Chapter 1: Question 12

Peptic ulcer disease Disorders of the esophagus

Table 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma

Barrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Myogenic Control. Esophageal Motility. Enteric Nervous System. Alimentary Tract Motility. Determinants of GI Tract Motility.

Esophageal Motility. Alimentary Tract Motility

GERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018

Esophageal Disorders. Learning Objectives. Introduction. Gastroesophageal Reflux Disease. Reza Shaker, MD, and Benson T.

SASKATCHEWAN REGISTERED NURSES ASSOCIATION

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Barrett s esophagus. Barrett s neoplasia treatment trends

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

Lahey Clinic Internal Medicine Residency Program: Curriculum for Gastroenterology

Gland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful in characterizing esophageal location

Gastro esophageal reflux disease DR. AMMAR I. ABDUL-LATIF

Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett s Esophagus

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma

PATHOLOGY OF NON NEOPLASTIC LESIONS OF THE UPPER GASTROINTESTINAL TRACT.

Current Management: Role of Radiofrequency Ablation

Body mass index: not a predictor for hiatus hernia of esophagus

235 60th Street, West New York, NJ T: (201) F: (201) Main Street, Hackensack, NJ T: (201)

1. Introduction. Correspondence should be addressed to Wei-Chen Tai; Received 29 May 2013; Accepted 5 July 2013

Gastroesophageal reflux disease (GERD) is the. Gastroesophageal Reflux Disease in the Elderly A SPECIAL ARTICLE INTRODUCTION PATHOGENESIS

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

National Digestive Diseases Information Clearinghouse

GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the

The relationship between length of Barrett s oesophagus mucosa and body mass index

A Multidisciplinary Approach to Esophageal Dysphagia: Role of the SLP. Darlene Graner, M.A., CCC-SLP, BRS-S Sharon Burton, M.D.

Magnifying Endoscopy and Chromoendoscopy of the Upper Gastrointestinal Tract

Rings in the esophagus are not always eosinophilic esophagitis: Case series of ring forming lymphocytic esophagitis and review of the literature

Introduction. Original articles. Nicolás Rocha, 1 Sandra Huertas, 2 Rosario Albis, 3 Diego Aponte, 4 Luis Carlos Sabbagh. 5

CLINICAL EFFECTIVENESS

National Digestive Diseases Information Clearinghouse

Identifying Intestinal Metaplasia at the Squamocolumnar Junction by Using Optical Coherence Tomography

Last Revised: September 15 Last Reviewed: September EOSINOPHILIC ESOPHAGITIS (EOE)/PPI-RESPONSIVE ESOPHAGEAL EOSINOPHILIA (PPI-REE)

Barrett s Oesophagus Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.

Hiatal Hernias and Barrett s esophagus. Dr Sajida Ahad Mercy General Surgery

Prevalence of Barrett s Esophagus in Bariatric Patients Undergoing Sleeve Gastrectomy

This medical position statement considers a series of

O esophageal adenocarcinoma (OA) has been reported

Faculty Disclosure. Objectives. State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) 24/11/2014

THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 97, No. 1, by Am. Coll. of Gastroenterology ISSN /02/$22.00

Disclosures. Gastroesophageal Reflux Disease. Gastroesophageal Reflux Disease

Chapter 2 Complications of Gastroesophageal Reflux Disease

Vital staining and Barrett s esophagus

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)

OESOPHAGITIS - A STUDY IN 301 PATIENTS

Present Day Management of Barrett s Esophagus

Esophageal Adenocarcinoma Arising from Barrett s Epithelium in Taiwan

Clinical Profile and Esophagogastroduodenoscopy Finding in Patients with Acid Peptic Disease at a Tertiary Health Care Centre

The incidence rates of adenocarcinoma of the esophagus. The Risk of Esophageal Adenocarcinoma After Antireflux Surgery. Methods Study Design

The normal esophagus is lined with squamous epithelium.

Association between Helicobacter Pylori Infection and Barrett s Esophagus in Patients with Gastro-Esophageal Reflux Symptoms and Erosive Esophagitis

Eosinophilic Esophagitis. Another Reason Not to Swallow

Gastrointestinal Disorders. Disorders of the Esophagus 3/7/2013. Congenital Abnormalities. Achalasia. Not an easy repair. Types

Current challenges in Barrett s esophagus

A PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS

GERD: A linical Clinical Clinical Update Objectives

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015

Disclosures. Proton Pump Inhibitors Deprescribing? Deprescribing PPI Objectives. Deprescribing. Proton Pump Inhibitors (PPI) 5/28/2018.

Prompt Upper Endoscopy Is an Appropriate Initial Management in Uninvestigated Chinese Patients With Typical Reflux Symptoms

Esophageal stricture causes and pattern of presentation at Ibn Sina Specialized Hospital Abstract Introduction: Methods: Results and discussion:

Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett s esophagus

Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori

Transcription:

Original Article Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease From Military Hospital, Rawalpindi Obaid Ullah Khan, Abdul Rasheed Correspondence: Dr. Abdul Rasheed, Consultant Physician Flat no: 8, Rukayya manzil, 339. Bohri bazar Saddar Hyderabad. Email: drsyedabdulrasheed@yahoo.com Received: April 7, 2008 accepted: June 18, 2008 ABSTRACT Objective: To determine frequency of Barrett s esophagus in patients with symptoms of gastroesophageal reflux disease (GERD). Patients and Methods: The Prospective, observational study was conducted at Department of Gastroenterology, Military hospital Rawalpindi Pakistan, from January 2005 to May 2005. One hundred fifty subjects with symptoms of GERD were included in the study. Upper gastrointestinal endoscopy was performed with Pentax EG 2940 to determine the underlying etiology. Three biopsy samples were taken to confirm the diagnosis. Results: Out of 150 subjects, 21(14%) were found to have Barrett s esophagus. The remaining 129(86%) showed inflammatory changes. Out of 21(14%) cases of Barrett s esophagus, 19(90.5%) were males and 2(9.5%) were females. Conclusion: Early upper gastrointestinal endoscopy and biopsy is recommended in patients with symptoms of GERD, as Barrett s esophagus is relatively common in our set up. (Rawal Med J 2008;33:205-207). Key words: Barrett s esophagus, gastroesophegeal reflux, GERD, endoscopy

2 INTRODUCTION Gastroesophageal reflux disease (GERD) is a common condition with its severity varying from often ignored retrosternal burning to a severe chest pain which keeps the patient up all night. 1 Physiologic reflux episodes are typically postprandial, short-lived and rarely occur during sleep while pathologic are more frequent and may occur during sleep. Reflux esophagitis describes a subset of patients with symptoms of GERD who have endoscopic or histopathologic evidence of esophageal inflammation. 2 Untreated, reflux esophagitis may lead to chronic complications such as Barrett's esophagus. Barrett's esophagus is an acquired premalignant condition characterized by progressive columnar metaplasia of the distal esophagus caused by longstanding gastroesophageal reflux and reflux esophagitis. Endoscopy and biopsy are required to make a diagnosis. 3 It is usually discovered during endoscopic examinations of middle-aged and older adults whose mean age at the time of diagnosis is approximately 55 years and rarely occurs before the age of five. 4 The sensitivity of endoscopy to detect Barrett's is related to the length of involved mucosa, with detection being more likely in patients who have long segment Barrett's. 5 The esophageal columnar metaplasia predisposes to the development of adenocarcinoma, 6 and thus such patients are advised to have regular endoscopic surveillance to detect early curable disease. 7 Barrett's esophagus was reportedly uncommon in blacks and Asians. 8 The aim of this study was to determine the current status of this entity in patients with GERD in our set up. PATIENTS AND METHODS This prospective observational study was conducted from January 2005 to May 2005 at Department of Gastroenterology, Military Hospital Rawalpindi. All subjects with age more than 18 years and symptoms of GERD (heart burn, retrosternal burning, water brash, globus sensation, chest pain, and regurgitation of more than three months duration) were enrolled in this study. Non-probability sampling technique was used and an informed consent was taken. Subjects with history of peptic ulcer disease, helicobacter pylori eradication therapy, positive HBsAg and anti-hcv antibodies, long term NSAID therapy, hiatus hernia and esophageal stricture were excluded.

3 Upper gastrointestinal endoscopy was performed on all patients with Pentax EG 2940. Lignocaine 4% spray and iv diazepam 5mg were used for premedication. Three biopsies were taken from 4 cms proximal to gastroesophageal junction. Findings were recorded in a previously designed proforma. The data were analyzed using SPSS 11.0 statistical software. RESULTS One hundred fifty subjects were enrolled in the study. Out of these, 112 (74.7%) were males and 38(25.3%) were females. Age ranged from 18 to 86 years with mean of 42±13.67 (Table 1). Twenty-one (14%) patients were found to have Barrett s esophagus on endoscopy. This was confirmed on histopathology. Remaining patients showed inflammatory changes. Out of 21(14%) cases of Barrett s esophagus, 19(90.5%) were males and 2(9.5%) were females. Majority of the male subjects 15(78.9%) were in the range of 18 to 38 years of age. Table 1. Endoscopic findings with age and gender. Gender Male Female Age (years) 18-38 39-59 60-80 > 80 18-38 39-59 60-80 Endoscopic findings Negative Positive 48 15 51.6% 78.9% 30 1 32.3% 5.3% 14 3 15.1% 15.8% 1-1.1% - 17 1 47.2% 50.0% 15 1 41.7% 50.0% 4-11.1% -

4 In patients other than Barrett s esophagus, various abnormalities like pangastritis (22%), antral gastritis (19.3%), mild antral gastritis (14%) and esophagitis (5%) were noted. Endoscopy was normal in 1.3%. Nine (42.9%) patients out of 21 cases of Barrett s esophagus had symptoms of gastroesophageal reflux in the range of 1-5 years duration and similar number was observed in the range of 6-10 years.14.3% had symptoms for more than 10 years (Table 2). Table 2. Duration of symptoms of GERD. Endoscopic findings Duration (years) Negative Positive 80 - Less than 1 62.0% - 49 9 1 5" 38.0% 42.9% - 9 6-10 - 42.9% - 3 More than 10-14.3% Total 129 21 Positive=Barrett s esophagus, Negative=other findings DISCUSSION An earlier study from Pakistan reported frequency rate of Barrett s esophagus to be 32% with mean age of patients 41.3 years and predominance of males. 9 Frequency of Barrett s esophagus in our study was 14 %, slightly higher than other studies. 6 The reason could be intake of spicy meals in our population resulting in gastroesophageal reflux. Mean age of patients was 42 years which is in accordance with the existing local data. 9 Male to female ratio was higher in our study. Nine (42.9%) out of 21 cases of Barrett s esophagus had

5 symptoms of GERD in the range of 1-5 years with similar number in the range of 6-10 years. Fourteen percent had symptoms for more than 10 years, which is near 37% reported in earlier study from Pakistan. 9 The lower frequency of Barrett s in Western developed countries may be the frequent use of diagnostic upper GI endoscopy in patients with symptoms of reflux. In our study, frequency of Barrett s esophagus was comparable to western countries but its complications like esophageal ulceration, stricture and hemorrhage are uncommon. In our country, diagnostic upper GI endoscopy is only performed when the symptoms are of severe intensity and are refractory to treatment. Thus, when patients undergo endoscopy, Barrett esophagus has already developed. In the present study, adenocarcinoma was not seen in any case with Barrett s esophagus. The frequency of adenocarcinoma in Barrett s esophagus has been reported in range from 0-37.5%. 11 The reliability of endoscopy for detection of Barrett's esophagus is approximately 80 percent. 12 GERD associated with Barrett's esophagus frequently is complicated by esophageal ulceration, stricture, and hemorrhage. Some studies have suggested that patients with a peptic stricture have a higher prevalence of Barrett's esophagus than those without strictures but this association has been challenged. 12 In conclusion, routine endoscopy and biopsy is recommended for patients with symptoms of GERD due to higher frequency of Barrett s esophagus in such individuals. Periodic endoscopic examination and biopsy should be done in patients with Barrett s esophagus for early detection of complications. Etiological factors and malignant transformation of Barrett s esophagus requires further studies.

6 REFERENCES 1. Ahmed SA, Naseemullah M, Mohammad K, Sheikh NI. Gastroesophageal reflux disease masquerading as upper respiratory illness and response to treatment. J Rawalpindi Med Coll 2000;4:11-3. 2. Richter JE. Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol Clin North Am 1996;25:75-102. 3. De Backer AI, De Schepper AM, Pelckmans P. The value of medical imaging in uncomplicated and complicated Barrett's esophagus. Acta Gastroenterol Belg 2000;63:22-8. 4. Hassall E. Columnar-lined esophagus in children. Gastroenterol Clin North Am 1997;26:533-48. 5. Csendes A, Smok G, Burdiles P, Quesada F, Huertas C, Rojas J, et al. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus 2000;13:5-11. 6. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825-31. 7. Spechler SJ. Esophageal complications of gastroesophageal reflux disease: presentation, diagnosis, management, and outcomes. Clin Cornerstone 2003; 5:41-8

7 8. Bersentes K, Fass R, Padda S, Johnson C, Sampliner RE. Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. Dig Dis Sci 1998; 43:1038-41. 9. Ansari AL, Sadiq S. Frequency, types and complications of Barrett`s Esophagus in patients with symptoms of Gastro-Esophageal Reflux. Pak J Med Sci 2004; 20:145-50. 10. Shalauta MD, Saad R. Barrett's esophagus. Am Fam Physician 2004; 69:2113-8 11. Mendes de Almeida JC, Chaves P, Pereira AD, Altorki NK. Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study. Ann Surg 1997;226:725-33. 12. Kim SL, Wo JM, Hunter JG, Davis LP, Waring JP. The prevalence of intestinal metaplasia in patients with and without peptic strictures. Am J Gastroenterol 1998;93:53-5.